PARAGON BIOSERVICES
Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the development and manufacturing of cutting-edge biopharmaceuticals. Paragon aims to build strong client partnerships with the world’s best biotech and pharma companies, focusing on transformative technologies, including gene therapies (AAV), next-generation vaccines, oncology immunotherapies (oncolytic viruses and CAR-T cell therapies), therapeutic prote... ins, and other complex biologics. The Company’s customer base has also transitioned from primarily substantial government contracts to now focus almost 100% on commercial activity servicing the biotech marketplace. The Company has retained Paragon’s core scientific talent while expanding its leadership team with new key senior hires who have a proven track record in GMP manufacturing. Each member of the current leadership team has over 20 years of industry experience and serves as the Company’s foundation to build a dominant CDMO in Maryland. Paragon now provides complete manufacturing services from process development and clinical manufacturing through commercial launch at its new 150,000 ft2 facility.
PARAGON BIOSERVICES
Industry:
Biotechnology Clinical Trials Manufacturing
Founded:
1990-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.paragonbioservices.com
Total Employee:
251+
Status:
Closed
Contact:
(410) 975-4050
Total Funding:
20 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Google Maps ReCAPTCHA Microsoft Azure DNS Google Maps API Japanese Yen Network Solutions DNS DocuSign
Current Employees Featured
Founder
Investors List
Camden Partners
Camden Partners investment in Series A - Paragon Bioservices
NewSpring
NewSpring investment in Series A - Paragon Bioservices
Newest Events participated
Participated in Gene Therapy for Rare Disorders 2017
on 2017-04-24 as sponsor
Official Site Inspections
http://www.paragonbioservices.com
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Paragon Bioservices"
Paragon Bioservices Company Profile 2024: Valuation, …
Information on acquisition, funding, investors, and executives for Paragon Bioservices. Use the PitchBook Platform to explore the full profile. Request a …See details»
Paragon Bioservices - Crunchbase Company Profile
Paragon Bioservices is an industry-leading, private-equity backed contract development and manufacturing organization (CDMO) whose focus is the …See details»
Catalent Has Acquired Paragon Bioservices
Catalent Has Acquired Paragon Bioservices. The acquisition will provide expertise and capabilities in one of the most exciting areas of healthcare, …See details»
Paragon Bioservices
Dec 10, 2024 Paragon Bioservices. 801 W. Baltimore Street, Suite 401. Baltimore, MD 21201 410-975-4050 . www.paragonbioservices.com Paragon Bioservices is a contract research and …See details»
Catalent to acquire gene therapy leader Paragon Bioservices
Apr 15, 2019 Paragon Bioservices, Inc. is an industry-leading, private-equity-backed contract development and manufacturing organization (CDMO) whose focus is the development and …See details»
BioPharmaLink profile of Paragon Bioservices, Inc., United States of ...
Paragon Bioservices, Inc.: Paragon is a GMP Contract Development & Manufacturing Organization (CDMO) delivering research, process development, and GMP manufacturing …See details»
1.2bn 11.9x NA - Bourne Partners
Paragon Bioservices, Inc. (“ParagonBioservices”)is a contract development and manufacturing organization (CDMO) that develops and manufactures biopharmaceuticals. The …See details»
Paragon Biosciences: Accelerating Life Science Innovation
Paragon is a global life science leader that creates, builds and funds innovative biology-based companies to treat and cure diseases.See details»
Paragon Bioservices - VentureRadar
Syngene (Biocon) India n/a Syngene is an innovation-led contract research, development, and manufacturing organization offering integrated scientific services from early discovery to …See details»
Catalent Completes Acquisition of Paragon Bioservices for $1.2B
May 20, 2019 Paragon Bioservices, Inc. is an industry-leading, private-equity-backed contract development and manufacturing organization (CDMO) whose focus is the development and …See details»
Paragon Bioservices, Inc. - Org Chart, Teams, Culture & Jobs - The …
Paragon Bioservices, Inc. 0 followers With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is a full-service partner for adeno-associated virus …See details»
Paragon Bioservices, Inc. Company Overview, Contact Details ...
Paragon Bioservices, Inc. Biotechnology Research Maryland, United States 10001+ Employees. With deep experience in viral vector scale-up and production, Catalent Cell & Gene Therapy is …See details»
NewSpring Portfolio Company Paragon Bioservices to be Acquired …
Apr 25, 2019 Paragon Bioservices, Inc. is an industry-leading, private-equity-backed contract development and manufacturing organization (CDMO) whose focus is the development and …See details»
Paragon Bioservices - Products, Competitors, Financials, …
Paragon Bioservices is a CRO-CMO whose focus is biopharmaceuticals including the production and purification of monoclonal antibodies, recombinant proteins, viral vectors and vaccines. …See details»
Paragon Bioservices company overview, insights, and reviews | Lensa
Paragon Bioservices believes in the core values of mutual respect, truth, fairness, integrity, scientific excellence, exceptional quality, and superior customer service. Having more than …See details»
Catalent to buy Paragon Bioservices for $1.2 billion: WSJ
Apr 14, 2019 Drug developer Catalent Inc has agreed to buy privately held, gene-therapy focused Paragon Bioservices Inc for $1.2 billion, the Wall Street Journal reported on Sunday, …See details»
Paragon announces its second GMP manufacturing facility and the ...
BALTIMORE, April 15, 2019 /PRNewswire/ -- Paragon Bioservices, the leading biologics contract development and manufacturing organization (CDMO) with proven expertise in gene therapy …See details»
Paragon Bioservices Celebrates Grand Opening of its World-Class …
BALTIMORE, April 11, 2019 /PRNewswire/ -- Paragon Bioservices, the leading private equity-backed biologics contract development and manufacturing organization (CDMO) with proven …See details»
Paragon Welcomes Employees to New 151,000 sq/ft Gene …
Paragon Welcomes Employees to New Gene Therapy Manufacturing Facility . After a week of persistent rain throughout Maryland, it was blue skies and a perfect 85-degree summer …See details»